Discover
GLSI
Greenwich LifeSciences, Inc.
18.99
2 x 11.52
2 x 20.59
bid
ask
+
0.60
3.26%
2 @ 07:47 PM
19.11 +0.12 (0.63%)
| Ytd | -9.61% | |
| 1y | 64.56% |
18.25
day range
20.04
7.85
52 week range
33.56
| Open | 18.40 | Prev Close | 18.39 | Low | 18.25 | High | 20.04 | Mkt Cap | 278.74M |
| Vol | 302.26K | Avg Vol | 148.71K | EPS | -1.59 | P/E | N/A | Forward P/E | -14.83 |
| Beta | 3.32 | Short Ratio | 21.41 | Inst. Own | 8.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 15.94 | 200-d Avg | 21.42 | 1yr Est | 38.00 |
| Income Statement | |||
| Operating Expenses | 4.02M | ||
| Research and Development Expense | 3.56M | ||
| Selling, General and Administrative Expense | 462.93K | ||
| Operating Income | -4.02M | ||
| Net Income | -3.95M | ||
| Net Income Common Stock | -3.95M | ||
| Net Income Common Stock (USD) | -3.95M | ||
| Consolidated Income | -3.95M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -3.95M | ||
| Earning Before Interest & Taxes (USD) | -3.95M | ||
| Weighted Average Shares | 14.62M | ||
| Weighted Average Shares Diluted | 14.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.88M | ||
| Cash and Equivalents (USD) | 8.88M | ||
| Current Assets | 8.88M | ||
| Total Assets | 8.88M | ||
| Current Liabilities | 5.76M | ||
| Total Liabilities | 5.76M | ||
| Accumulated Retained Earnings (Deficit) | -96.74M | ||
| Shareholders Equity | 3.12M | ||
| Shareholders Equity (USD) | 3.12M | ||
| Trade and Non-Trade Payables | 5.03M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 310.66K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.63M | ||
| Issuance (Purchase) of Equity Shares | 310.66K | ||
| Net Cash Flow from Operations | -1.94M | ||
| Share Based Compensation | 1.48M | ||